Tri-Manganese(III) Salen-Based Cryptands: A Metal Cooperative Antioxidant Strategy that Overcomes Ischemic Stroke Damage


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
03 06 2020
Historique:
pubmed: 12 5 2020
medline: 14 4 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

Oxidative stress is one of the hallmarks of ischemic stroke. Catalase-based (CAT) biomimetic complexes are emerging as promising therapeutic candidates that are expected to act as neuroprotectants for ischemic stroke by decreasing the damaging effects from H

Identifiants

pubmed: 32390429
doi: 10.1021/jacs.0c03805
doi:

Substances chimiques

Antioxidants 0
Coordination Complexes 0
Ethylenediamines 0
Neuroprotective Agents 0
Manganese 42Z2K6ZL8P
disalicylaldehyde ethylenediamine 94-93-9
Catalase EC 1.11.1.6
Oxygen S88TT14065

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10219-10227

Auteurs

Yingying Ning (Y)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Yan Huo (Y)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, People's Republic of China.

Haozong Xue (H)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Yujing Du (Y)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, People's Republic of China.

Yuhang Yao (Y)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Adam C Sedgwick (AC)

Department of Chemistry, The University of Texas at Austin, 105 East 24th Street-A5300, Austin, Texas 78712-1224, United States.

Hengyu Lin (H)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Cuicui Li (C)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, People's Republic of China.

Shang-Da Jiang (SD)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Bing-Wu Wang (BW)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Song Gao (S)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.
School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510640, People's Republic of China.

Lei Kang (L)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, People's Republic of China.

Jonathan L Sessler (JL)

Department of Chemistry, The University of Texas at Austin, 105 East 24th Street-A5300, Austin, Texas 78712-1224, United States.

Jun-Long Zhang (JL)

Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH